|Bid||0.00 x 20000|
|Ask||0.00 x 20000|
|Day's Range||205.15 - 205.15|
|52 Week Range||179.62 - 255.50|
|Beta (5Y Monthly)||0.45|
|PE Ratio (TTM)||40.54|
|Earnings Date||Aug 03, 2022 - Aug 08, 2022|
|Forward Dividend & Yield||1.61 (0.80%)|
|Ex-Dividend Date||May 11, 2022|
|1y Target Est||261.67|
Lucile Blaise, President, Sleep & Respiratory Care, ResMed Lucile Blaise, President, Sleep & Respiratory Care, ResMed Blaise is a medtech industry thought leader with over 25 years’ experienceA board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech associationPromotion effective July 1 SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective Ju
Every investor in ResMed Inc. ( NYSE:RMD ) should be aware of the most powerful shareholder groups. Large companies...
ResMed's (RMD) acquisition of a renowned out-of-hospital software solutions company is expected to strengthen its SaaS business.